Back to Search Start Over

Consensus-based recommendations for optical coherence tomography angiography reporting in uveitis.

Authors :
Pichi F
Carreño E
Pavesio C
Denniston AK
Grewal DS
Deak G
Khairallah M
Ruiz-Cruz M
de Oliveira Dias JR
Adan A
Burke T
Invernizzi A
Schlaen A
Tian M
Agarwal AK
Tucker WR
Sen HN
Lin P
Lim LL
Pepple KL
Munk MR
Source :
The British journal of ophthalmology [Br J Ophthalmol] 2023 Jul; Vol. 107 (7), pp. 959-965. Date of Electronic Publication: 2022 Feb 08.
Publication Year :
2023

Abstract

Background/aims: To establish a consensus in the nomenclature for reporting optical coherence tomography angiography (OCTA findings in uveitis.<br />Methods: The modified Delphi process consisted of two rounds of electronic questionnaires, followed by a face-to-face meeting conducted virtually. Twenty-one items were included for discussion. The three main areas of discussion were: wide field OCTA (WF-OCTA), nomenclature of OCTA findings and OCTA signal attenuation assessment and measurement. Seventeen specialists in uveitis and retinal imaging were selected by the executive committee to constitute the OCTA nomenclature in Uveitis Delphi Study Group. The study endpoint was defined by the degree of consensus for each question: 'strong consensus' was defined as >90% agreement, 'consensus' as 85%-90% and 'near consensus' as >80% but <85%.<br />Results: There was a strong consensus to apply the term 'wide field' to OCTA images measuring over 70° of field of view, to use the terms 'flow deficit' and 'non-detectable flow signal' to describe abnormal OCTA flow signal secondary to slow flow and to vessels displacement respectively, to use the terms 'loose' and 'dense' to describe the appearance of inflammatory choroidal neovascularisation, and to use the percentage of flow signal decrease to measure OCTA ischaemia with a threshold greater than or equal to 30% as a 'large area'.<br />Conclusions: This study sets up consensus recommendations for reporting OCTA findings in uveitis by an expert panel, which may prove suitable for use in routine clinical care and clinical trials.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
1468-2079
Volume :
107
Issue :
7
Database :
MEDLINE
Journal :
The British journal of ophthalmology
Publication Type :
Academic Journal
Accession number :
35135783
Full Text :
https://doi.org/10.1136/bjophthalmol-2021-320021